ATRICURE ENROLLS FIRST PATIENT IN SOLE-TERAPY MINIMALLY INVASIVE CLINICAL STUDY

AtriCure, a medical device company focused on developing, manufacturing and selling innovative surgical devices, recently announced the enrollment and treatment of the first patient in its RESTORE-SR II clinical study for the use of the AtriCure Bipolar Ablation System in a sole-therapy, minimally invasive procedure to treat atrial fibrillation (AF).

Yahoo News (http://biz.yahoo.com/prnews/051031/nym027.html?.v=28)